T. Rowe Price Investment Management Inc. Lowers Stock Position in Lam Research Corporation $LRCX

Key Points

• T. Rowe Price Investment Management Inc. has reduced its stake in Lam Research Corporation by 61.7%, selling 90,883 shares to hold only 56,397 shares worth approximately $4,101,000.
• Lam Research has seen significant increases in holdings from other hedge funds, with Brighton Jones LLC boosting its stake by 1,032.4% and Price T Rowe Associates increasing theirs by 305.3%.
• Analysts have rated Lam Research with a consensus of Moderate Buy and a price target of $107.30, following recent increases in price targets by firms like Oppenheimer and UBS Group.

T. Rowe Price Investment Management Inc. cut its holdings in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 61.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 56,397 shares of the semiconductor company's stock after selling 90,883 shares during the period. T. Rowe Price Investment Management Inc.'s holdings in Lam Research were worth $4,101,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in LRCX. Vanguard Group Inc. grew its stake in shares of Lam Research by 6.9% in the first quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company's stock worth $9,389,358,000 after purchasing an additional 8,364,375 shares during the last quarter. Ameriprise Financial Inc. grew its position in shares of Lam Research by 950.5% in the 4th quarter. Ameriprise Financial Inc. now owns 34,543,915 shares of the semiconductor company's stock valued at $2,495,128,000 after buying an additional 31,255,726 shares during the last quarter. Invesco Ltd. increased its stake in shares of Lam Research by 2.8% in the first quarter. Invesco Ltd. now owns 17,330,771 shares of the semiconductor company's stock valued at $1,259,947,000 after buying an additional 472,636 shares during the period. Northern Trust Corp raised its position in shares of Lam Research by 1,067.0% during the fourth quarter. Northern Trust Corp now owns 15,869,244 shares of the semiconductor company's stock worth $1,146,235,000 after acquiring an additional 14,509,407 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Lam Research by 6,383.5% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,574,691 shares of the semiconductor company's stock worth $980,500,000 after acquiring an additional 13,365,317 shares during the period. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research Stock Down 3.8%

NASDAQ LRCX traded down $3.94 during mid-day trading on Friday, hitting $100.15. The company's stock had a trading volume of 12,177,963 shares, compared to its average volume of 11,487,494. The firm has a market capitalization of $126.75 billion, a price-to-earnings ratio of 24.07, a PEG ratio of 1.29 and a beta of 1.65. The company's 50 day simple moving average is $99.45 and its 200 day simple moving average is $85.29. The company has a current ratio of 2.21, a quick ratio of 1.55 and a debt-to-equity ratio of 0.38. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $108.02.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, beating analysts' consensus estimates of $1.21 by $0.12. The firm had revenue of $5.17 billion for the quarter, compared to analyst estimates of $4.99 billion. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The business's quarterly revenue was up 33.6% compared to the same quarter last year. During the same period last year, the firm earned $1.03 earnings per share. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, September 24th will be paid a dividend of $0.26 per share. This is an increase from Lam Research's previous quarterly dividend of $0.23. The ex-dividend date is Wednesday, September 24th. This represents a $1.04 dividend on an annualized basis and a yield of 1.0%. Lam Research's dividend payout ratio (DPR) is presently 22.12%.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. Wall Street Zen raised shares of Lam Research from a "hold" rating to a "buy" rating in a research report on Saturday, August 2nd. Cantor Fitzgerald increased their price objective on shares of Lam Research from $115.00 to $120.00 and gave the stock an "overweight" rating in a research report on Thursday, August 21st. Wells Fargo & Company set a $98.00 target price on shares of Lam Research and gave the stock an "equal weight" rating in a research note on Thursday, July 31st. B. Riley reiterated a "buy" rating and set a $115.00 price target (up from $95.00) on shares of Lam Research in a report on Wednesday, June 18th. Finally, Mizuho boosted their price objective on Lam Research from $115.00 to $120.00 and gave the company an "outperform" rating in a research note on Friday, August 1st. Twenty equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $107.30.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.